This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slipped 1.90% to $2.58 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.92% to 3,863.16 and the Dow Jones Industrial Average DJIA rising 2.15% to 31,288.26. This was the stock's second consecutive day of losses. Ocugen Inc. closed $15.07 below its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. ADVM fell 5.71% to $1.65, Ocular Therapeutix Inc. OCUL rose 0.70% to $4.33, and Kodiak Sciences Inc. KOD remained unchanged. Trading volume (5.1 M) remained 1.8 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 15, 2022.
(END) Dow Jones Newswires
July 15, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.